Phase 2 study of ibrutinib in relapsed or refractory mantle cell lymphoma: updated safety analysis on prevalence of infection, diarrhea, and bleeding over time

S. Rule, M. L. Wang, P. Martin, R. Auer, B. S. Kahl, W. Jurczak, R. H. Advani, J. Romaguera, M. Williams, J. C. Barrientos, E. Chmielowska, J. A. Radford, S. Stilgenbauer, V. Truong, M. Chang, D. M. Beaupre, A. Goy, K. A. Blum

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article numberP461
Pages (from-to)150-150
Number of pages1
JournalHaematologica
Volume99
Issue numberSupplement 1
Publication statusPublished - 2014
Event19th Congress of the European Hematology Association - Milan, Italy
Duration: 12 Jun 201415 Jun 2014

Cite this